Coya Therapeutics Inc. (NASDAQ: COYA)
$6.5400
+0.4600 ( +4.81% ) 46.2K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$6.5400
Previous close
$6.0800
Volume
46.2K
Market cap
$109.59M
Day range
$6.0850 - $6.5900
52 week range
$4.7500 - $10.6899
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |
| 4 | Insider transactions | 1 | Nov 12, 2024 |
| 4 | Insider transactions | 1 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 56 | Nov 06, 2024 |
| 8-k | 8K-related | 12 | Nov 06, 2024 |
| 8-k | 8K-related | 13 | Nov 05, 2024 |
| 8-k | 8K-related | 15 | Oct 31, 2024 |
| 8-k | 8K-related | 31 | Oct 29, 2024 |
| 8-k | 8K-related | 15 | Oct 22, 2024 |